Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 58, Issue 10, 2009, Pages 1477-1482

  Viktorínová, Alena ^a   Tošerová, Eva ^a   Križko, Marián ^a   Ďuračková, Zdenka ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; COPPER; GLYCOSYLATED HEMOGLOBIN; MAGNESIUM; ZINC;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; DISEASE COURSE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; ZINC BLOOD LEVEL; ZINC METABOLISM;

COPPER; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; SPECTROPHOTOMETRY, ATOMIC; ZINC;

EID: 70149085206     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.04.035     Document Type: Article

References (30)

1. Aguilar M.V., Saavedra P., Arrieta F.J., et al. Plasma mineral content in type-2 diabetic patients and their association with metabolic syndrome. Ann Nutr Metab 51 (2007) 402-406
2. Zheng Y., Li X.K., and Cai L. The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 32 (2008) 135-144
3. Ryu S., Ornoy A., samuni A., et al. Oxidative stress in Cohen diabetic rat model by high-sucrose, low-copper diet: inducing pancreatic damage and diabetes. Metabolism 57 (2008) 1253-1261
4. Van Campenhout A., Van Campenhout C., Lagrou A.R., et al. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status. Diabetes Metab Res Rev 22 (2006) 444-454
5. Ďuračková Z. Oxidants, antioxidants and oxidative stress. In: Gvozdjáková A. (Ed). Mitochondrial medicine (2008), Springer, Amsterdam 19-49
6. Forbes J.M., Coughlan M.T., and Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57 (2008) 1446-1454
7. Muchová J., Liptáková A., Országhová Z., et al. Antioxidant system in polymorphonuclear leukocytes of type 2 diabetes mellitus. Diabet Med 16 (1999) 74-78
8. Eaton J.W., and Qian M. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Cell Biochem 234-235 (2002) 135-142
9. Chausmer A.B. Zinc, insulin and diabetes. J Am Coll Nutr 17 (1998) 109-115
10. Champagne C.M. Magnesium in hypertension, cardiovascular disease, metabolic syndrome and other conditions: a review. Nutr Clin Pract 23 (2008) 142-151
11. Soinio M., Marniemi J., Laakso M., et al. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care 30 (2007) 523-528
12. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 49 (2000) 27-29
13. DiSilvestro R.A. Zinc in relation to diabetes and oxidative disease. J Nutr 130 (2000) 1509S-1511S
14. Valko M., Morris H., and Cronin M.T. Metals, toxicity and oxidative stress. Curr Med Chem 12 (2005) 1161-1208
15. Prasad A.S., Bao B., Beck F.W., Kucuk O., and Sarkar F.H. Antioxidant effect of zinc in humans. Free Rad Biol Med 37 (2004) 1182-1190
16. Opara E.C. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Health 122 (2002) 28-34
17. Schlienger J.L., Grunenberger F., Maier E.A., et al. Disorders of plasma trace elements in diabetes. Relation to blood glucose equilibrium. Presse Med 28 (1998) 1076-1079
18. Walter R.M., Uriu-Hare J.Y., Olin K.L., et al. Copper, zinc, manganese and magnesium status and complications of diabetes mellitus. Diabetes Care 14 (1991) 1050-1056
19. Galhardi C.M., Diniz Y.S., Faine L.A., et al. Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction. Food Chem Toxicol 42 (2004) 2053-2060
20. Quraishi I., Collins S., Pestaner J.P., Harris T., and Bagasra O. Role of zinc and zinc transporters in the molecular pathogenesis of diabetes mellitus. Med Hypotheses 65 (2005) 887-892
21. Huerta M.G., Roemmich J.N., Kington M.L., et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 28 (2005) 1175-1181
22. Eibl N.L., Kopp H.P., Nowak H.R., et al. Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care 18 (1995) 188-192
23. Wells I.C. Evidence that the etiology of the syndrome containing type 2 diabetes mellitus. results from abnormal magnesium metabolism. Can J Physiol Pharmacol 86 (2008) 16-24
24. Guerrero-Romero F., and Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation and metabolic syndrome. Diabetes Metab Res Rev 22 (2006) 471-476
25. Wälti M.K., Zimmermann M.B., Spinas G.A., and Hurrell R.F. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly 133 (2003) 289-292
26. Gums J.G. Magnesium in cardiovascular and other disorders. Am J Health-Syst Pharm 61 (2004) 1569-1576
27. Qi J.-X. Determination of Cu, Zn, Fe, Ca, Mg, Na and K in serum flame by atomic absorption spectroscopy. Varian AA Instruments At Work (1990) AA-93
28. Ghayour-Mobarhan M., Taylor A., New S.A., Lamb D.J., and Ferns G.A. Determinants of serum copper, zinc and selenium in healthy subjects. Ann Clin Biochem 42 (2005) 364-375
29. Ruíz C., Alegria A., Barberá R., Farré R., and Lagarda J. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol 12 (1998) 91-95
30. Quilliot D., Walters E., Bonte J.P., et al. Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis. Am J Clin Nutr 81 (2005) 1117-1125